Poseida Therapeutics
View On Demand

Three Platforms. Unlimited Opportunities.

About the Event

Poseida Therapeutics (NASDAQ: PSTX) has developed proprietary platforms for gene editing, gene insertion, and gene delivery that can be combined in different ways to treat an almost unlimited array of genetic disorders and other chronic illnesses including cancer.

In fact, the company just received clearance of its Investigational New Drug (IND) application from the FDA for a new allogeneic CAR-T candidate. It has the potential to treat a wide range of solid tumors such as breast, colorectal, lung, ovarian, pancreatic, renal, and other cancers.

Join our webinar to hear from the Poseida leadership team about their pipeline of CAR-T and Gene Therapies, and why they’ve received strategic investments from companies including Novartis and Fidelity.

View On-Demand Webinar

Share on facebook
Share on twitter
Share on linkedin

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.